IGF2BP2 and pancreatic neoplasm: Interestingly, DANCR is modified at N6-methyladenosine (m6A), whereas IGF2BP2 serves a reader for m6A-modified DANCR and stabilizes DANCR RNA in pancreatic cancer (Hu et al., 2020).